Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence
Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence
Recruiting · NCT05952934 · Registry updated 2026-09-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma | Recruiting | Phase 2 | 2026-09-15 | NCT05952934 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Highlands Oncology Group, PA | 1 |
| NYU Langone Health | 359 |
| University of Arkansas | 76 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Highlands Oncology Group, PA | Fayetteville | United States | 1 |
| Highlands Oncology Group, PA | Springdale | United States | 12 |
| Highlands Oncology Group, PA | Rogers | United States | 1 |
| Perlmutter Cancer Center at NYU Langone Health | Mineola | United States | 1 |
| Perlmutter Cancer Center at NYU Langone Health | New York | United States | 4 |
| University of Arkansas for Medical Sciences | Little Rock | United States | 218 |